| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |